Department of Orthopaedic Surgery, Sint Maartenskliniek, Nijmegen, The Netherlands.
Sint Maartenskliniek Research, Nijmegen, The Netherlands.
J Shoulder Elbow Surg. 2020 Apr;29(4):768-774. doi: 10.1016/j.jse.2019.11.027.
We hypothesized that benzoyl peroxide (BPO) would reduce the presence of Cutibacterium acnes on the skin of the shoulder by 50% compared with placebo. Infections after shoulder surgery are most commonly caused by C acnes. Current prophylactic methods do not effectively reduce the bacterial load of this bacterium. However, it seems that BPO may reduce C acnes on the skin of the shoulder. Therefore, this study aimed to investigate the effect of BPO on the presence of C acnes on the shoulder skin.
A double-blinded, randomized, placebo-controlled trial was performed including healthy participants aged between 40 and 80 years. Thirty participants with C acnes on the shoulder skin according to baseline skin swabs were randomized into the BPO or placebo group. After gel application 5 times, skin swabs were taken to determine the presence of C acnes.
Forty-two participants were screened for the presence of C acnes to include 30 participants with the bacterium. Participants with C acnes at baseline were 7.4 years younger than participants without C acnes (P = .015). One participant in the placebo group dropped out before application because of fear of adverse events. After application, C acnes remained present in 3 of 15 participants (20.0%) in the BPO group and in 10 of 14 participants (71.4%) in the placebo group, resulting in a 51.4% reduction in the presence of C acnes.
Applying BPO 5 times on the shoulder skin effectively reduces C acnes. Consequently, BPO may reduce the risk of postoperative infections.
我们假设过氧化苯甲酰(BPO)与安慰剂相比,可将肩部皮肤的痤疮丙酸杆菌减少 50%。肩部手术后的感染最常由 C 痤疮丙酸杆菌引起。目前的预防方法并不能有效降低这种细菌的细菌负荷。然而,BPO 似乎可以减少肩部皮肤的 C 痤疮丙酸杆菌。因此,本研究旨在探讨 BPO 对肩部皮肤 C 痤疮丙酸杆菌存在的影响。
一项双盲、随机、安慰剂对照试验,纳入年龄在 40 至 80 岁之间的健康参与者。根据基线皮肤拭子,30 名肩部皮肤有 C 痤疮丙酸杆菌的参与者被随机分为 BPO 或安慰剂组。在凝胶应用 5 次后,取皮肤拭子以确定 C 痤疮丙酸杆菌的存在。
对 42 名参与者进行了 C 痤疮丙酸杆菌的筛查,以纳入 30 名有该细菌的参与者。基线时 C 痤疮丙酸杆菌的参与者比无 C 痤疮丙酸杆菌的参与者年轻 7.4 岁(P =.015)。由于担心不良反应,安慰剂组的一名参与者在应用前退出。应用后,BPO 组 15 名参与者中有 3 名(20.0%)和安慰剂组 14 名参与者中有 10 名(71.4%)仍存在 C 痤疮丙酸杆菌,C 痤疮丙酸杆菌的存在减少了 51.4%。
在肩部皮肤涂抹 BPO 5 次可有效减少 C 痤疮丙酸杆菌。因此,BPO 可能降低术后感染的风险。